⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
GLSI News
Greenwich LifeSciences, Inc.
Greenwich LifeSciences Announces FDA Approves Use of Commercially Manufactured GP2 in FLAMINGO-01
globenewswire.com
GLSI
How $594B in Precision Tech is Cracking the Metastatic Cancer Code
prnewswire.com
ONCY
BCTX
GLSI
CTOR
KZIA
Greenwich LifeSciences Extends Lock-up of Directors and Officers to September 30, 2026
globenewswire.com
GLSI
Greenwich LifeSciences Provides Additional Updates on FLAMINGO-01 and Corporate Strategy
globenewswire.com
GLSI
Greenwich LifeSciences Announces Preliminary Analysis Showing 80% Recurrence Rate Reduction in the Open Label Arm of FLAMINGO-01
globenewswire.com
GLSI
Greenwich LifeSciences Announces Completion of Enrollment in the Open Label Arm of FLAMINGO-01
globenewswire.com
GLSI
Greenwich LifeSciences Provides Global Update on FLAMINGO-01, Screening Over 1,000 Patients to Date
globenewswire.com
GLSI
Greenwich LifeSciences Announces Addition of Austria to Flamingo-01 Clinical Trial
globenewswire.com
GLSI
Greenwich LifeSciences Announces Expansion of Flamingo-01 Clinical Trial to Belgium
globenewswire.com
GLSI
Greenwich LifeSciences Announces Addition of Portugal to Flamingo-01 Clinical Trial
globenewswire.com
GLSI